News By Tag
News By Place
Follow on Google News
Global Hemophilia Market (By Treatment Regimen, Type & Therapy): Insights & Forecast (2023-2027)
The competitive landscape of the market, along with the company profiles of leading players (Pfizer Inc., Bayer Group, Sanofi S.A., Takeda Pharmaceutical Company, Novo Nordisk and CSL Limited) are also presented in detail.
By: Koncept Analytics
The global hemophilia market by treatment regimen can be segmented as follows: prophylaxis and on-demand. In 2022, the higher share was held by prophylaxis segment, followed by on-demand segment. The global hemophilia market by type can be segmented into the following: hemophilia A and hemophilia B, where hemophilia A held a larger share of the market in 2022. The global hemophilia market by therapy can be segmented as follows: replacement therapy and ITI therapy. The dominant share of the market in 2022 was held by replacement therapy segment.
The global hemophilia market by region can be segmented into the following regions: North America, Europe and Asia Pacific. In 2022, the dominant share of the market was held by North America, followed by Europe and Asia Pacific. The factors like rising prevalence of hemophilia, growing knowledge amongst individuals regarding different treatment methods and surging inclination towards prophylaxis treatment contributed towards growth in the North American market.
Scope of the report:
For more Information:
(Business Development Manager)
FFCS-36, Ansal Plaza
U.P - 201010
Mail ID – email@example.com